{
  "@context": "aku-v2",
  "@type": "procedure",
  "@id": "vasc:vm:venous-sclerotherapy",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:20:00.000Z",
    "updated": "2026-01-07T03:20:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.92,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vascular-malformations",
    "type": "interventional-procedure",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "title": "Venous Malformation Sclerotherapy",
    "description": "Percutaneous sclerotherapy for low-flow venous malformations",
    "key_concepts": [
      {
        "concept": "Indications",
        "details": "Symptomatic venous malformations causing pain, functional impairment, cosmetic concerns"
      },
      {
        "concept": "Agents",
        "details": "Ethanol, sodium tetradecyl sulfate (STS), polidocanol, bleomycin"
      },
      {
        "concept": "Technique",
        "details": "Direct puncture under ultrasound or fluoroscopic guidance; venography to assess drainage"
      },
      {
        "concept": "Outcomes",
        "details": "Multiple sessions often required; improvement in 80-90% but complete resolution uncommon"
      }
    ],
    "clinical_significance": "Sclerotherapy is first-line treatment for symptomatic venous malformations"
  },
  "provenance": {
    "primary_sources": ["Dompmartin A et al. J Vasc Surg 2010"]
  }
}
